Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Casemanagement dementie al verzekerde zorg vanaf ‘niet pluis’-fase
mei 2024 | Dementie